Preview Mode Links will not work in preview mode

The Retina Channel Podcast

The Retina Channel is an ophthalmology journal club discussing new scientific articles focused on retina. The target audience are eye care professionals who are interested in the most recent advances in retina.

“Our mission is to facilitate transmission of knowledge from researchers to their target audience.”

  1. All Episodes
  2. E23- CANTREAT Study. Ranibizumab Monthly vs Treat-and-Extend for wAMD - Dr. Peter Kertes

E23- CANTREAT Study. Ranibizumab Monthly vs Treat-and-Extend for wAMD - Dr. Peter Kertes

Feb 22, 2019

Dr. Peter Kertes discusses the publication of the first year results of the CANTREAT study that investigates monthly vs treat-and-extend dosing of ranibizumab for wet AMD. 

 

Full reference:

Kertes, P. J., Galic, I. J., Greve, M., Williams, R. G., Rampakakis, E., Scarino, A., & Sheidow, T. (2019). Canadian Treat and Extend Analysis Trial with Ranibizumab in Patients with Neovascular Age-related Macular Disease: 1-Year Results of the Randomized CANTREAT Study. Ophthalmology. doi:10.1016/j.ophtha.2019.01.013